You are here


The Covid-19 vaccine fight is getting ugly

National self-interest and pressure for Big Pharma to turn a profit are leading to a geopolitical bust-up over who gets access to the vaccine first.

The pandemic has revealed a lot of problems in the pharmaceutical supply chain, from a dependence on emerging markets for vital drug supplies to a lack of interest in potentially unprofitable vaccine research.

AN EFFECTIVE Covid-19 vaccine, if it ever arrives, should be treated as a public good for the whole of society. Every continent has been struck by the novel coronavirus bar Antarctica.

But the combination of national self-interest and pressure for the pharmaceutical industry to turn a...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to